Emmanuelle Charpentier

Braunschweig, Germany

Emmanuelle Charpentier

USPTO Granted Patents = 61 

 

 

Average Co-Inventor Count = 4.0

ph-index = 11

Forward Citations = 427(Granted Patents)

Forward Citations (Not Self Cited) = 402(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Braunschweig, DE (2018 - 2023)
  • Berlin, DE (2021 - 2024)

Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
RNA-Directed Target DNA Modification
Transcription Modulation
Gene Editing Techniques
CRISPR Technology
Nucleic Acid Therapeutics
Genetic Engineering
Molecular Biology
Biotechnology Innovations
Synthetic Biology
Genome Editing
RNA Interference
Gene Regulation
61 patents (USPTO):Explore Patents

As an AI assistant focusing on innovations, inventions, inventors, patent attorneys, assignees, and patents, I can certainly help you with that. Here is the article about inventor Emmanuelle Charpentier:

Title: The Innovative Mind of Emmanuelle Charpentier: Revolutionizing Genome Editing

Introduction:

Emmanuelle Charpentier, a prominent inventor based in Braunschweig, DE, is renowned for his groundbreaking work in genome editing. With an impressive portfolio of 56 patents, Charpentier has significantly contributed to advancements in biotechnology and genetic engineering.

Latest Patents:

Charpentier's latest patents include "Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription." These patents focus on utilizing DNA-targeting RNA and modifying polypeptides to achieve site-specific modifications in target DNA and polypeptides associated with it. Additionally, the patents cover methods for modulating transcription using enzymatically inactive Cas9 polypeptides and DNA-targeting RNA, along with the development of genetically modified cells and transgenic organisms.

Career Highlights:

Having worked at prestigious institutions such as the University of California and the University of Vienna, Charpentier has demonstrated excellence in his field. His research has paved the way for new possibilities in genetic manipulation, opening doors for potential therapeutic applications and advancements in biomedicine.

Collaborations:

Throughout his career, Emmanuelle Charpentier has collaborated with esteemed colleagues, including Jennifer A. Doudna and Martin Jinek. These collaborations have led to significant discoveries and innovative solutions in the realm of genome editing.

Conclusion:

In conclusion, Emmanuelle Charpentier's relentless pursuit of innovation and his pioneering spirit have established him as a key figure in the field of genetic engineering. With a diverse range of patents and a remarkable career trajectory, Charpentier continues to inspire and drive advancements in biotechnology, ultimately shaping the future of scientific research and development.

If you have any more requests or need further assistance in the realm of innovations, inventions, inventors, patent attorneys, assignees, or patents, feel free to ask.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…